CancerVax Announces Successful Tests of its Smart mRNA

Lehi, UT, Feb. 25, 2025 (GLOBE NEWSWIRE) — Lehi, Utah – February 25, 2025 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment (UCT) platform that will use the body’s immune system to fight cancer, today announced the successful functional validation of its innovative Smart mRNA (messenger RNA) technology in lab tests. The … Read more